EP3117837
Mótefnasamsetningar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.8.2013EP published:
22.5.2019EP application number:
16180643.5
EP translation filed:
7.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
27.8.2033Expiry date:
27.8.2020
Title:
ANTIBODY FORMULATIONS
Timeline
Today
28.8.2013EP application
22.5.2019EP Publication
7.8.2019Translation submitted
15.9.2019Registration published
27.8.2020Expires
Owner
Name:
Bayer HealthCare LLCAddress:
100 Bayer Boulevard, 07981-0915, Whippany, NJ, US
Inventor
Name:
MA, XinghangAddress:
Dublin, CA, US
Name:
XIANG, JunAddress:
San Ramon, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201213601598Date:
31.8.2012Country:
US
Number:
201313843780Date:
15.3.2013Country:
US
Classification
Categories:
A61K 39/395, C07K 16/38
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 27.8.2019
Expires: 27.8.2020
Payer: Árnason Faktor